March 30 (Reuters) – Britain’s FTSE 100 index is seen opening 30 points higher at 6,767 on Tuesday, according to financial bookmakers.
* GLAXOSMITHKLINE: GlaxoSmithKline has agreed in principle to handle the final part of the manufacturing process for up to 60 million doses of Novavax ‘s COVID-19 vaccine for use in Britain, widening the company’s role in the fight against the pandemic. ASTRAZENECA: Canadian health officials said on Monday they would stop offering AstraZeneca’s COVID-19 vaccine to people under age 55 and require a new analysis of the shot’s risks and benefits based on age and gender. IPO: Brazilian energy firm Raizen, a joint venture between Cosan SA and Royal Dutch Shell PLC , has chosen four investment banks to manage its initial public offering, raising up to 13 billion reais, four people familiar with the matter said on Monday. GOLD: prices slipped weighed down by a firm U.S. dollar and Treasury yields as expectations of a swift economic turnaround grew with vaccination rates gaining traction. OIL: Oil prices fell as shipping traffic resumed through the Suez Canal after days on hold and attention switched to an OPEC+ meeting this week where the extension of supply curbs may be on the table amid new coronavirus pandemic lockdowns. The UK blue-chip index closed 0.08% lower on Monday, as weakness in banks and consumer discretionary stocks outweighed gains in defensive sectors. UK CORPORATE DIARY:
Royal Mail
Trading statement Pennon Group
Trading statement A.G. Barr
FY results Imperial Brands
Trading statement
* For more on the factors affecting European stocks, please click on: LIVE/
TODAY’S UK PAPERS
> Financial Times
PRESS/FT
> Other business headlines
PRESS/GB
Source link